289 related articles for article (PubMed ID: 26501352)
1. Effect of Some Psychoactive Drugs Used as 'Legal Highs' on Brain Neurotransmitters.
Gołembiowska K; Jurczak A; Kamińska K; Noworyta-Sokołowska K; Górska A
Neurotox Res; 2016 Apr; 29(3):394-407. PubMed ID: 26501352
[TBL] [Abstract][Full Text] [Related]
2. 5-hydroxytryptamine- and dopamine-releasing effects of ring-substituted amphetamines on rat brain: a comparative study using in vivo microdialysis.
Matsumoto T; Maeno Y; Kato H; Seko-Nakamura Y; Monma-Ohtaki J; Ishiba A; Nagao M; Aoki Y
Eur Neuropsychopharmacol; 2014 Aug; 24(8):1362-70. PubMed ID: 24862256
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the neurotoxicity of N-methyl-1-(4-methoxyphenyl)-2-aminopropane (para-methoxymethamphetamine, PMMA).
Steele TD; Katz JL; Ricaurte GA
Brain Res; 1992 Sep; 589(2):349-52. PubMed ID: 1382813
[TBL] [Abstract][Full Text] [Related]
4. 3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter.
Anneken JH; Angoa-Pérez M; Kuhn DM
J Neurochem; 2015 Apr; 133(2):211-22. PubMed ID: 25626880
[TBL] [Abstract][Full Text] [Related]
5. Neurotoxic Effects of 5-MeO-DIPT: A Psychoactive Tryptamine Derivative in Rats.
Noworyta-Sokołowska K; Kamińska K; Kreiner G; Rogóż Z; Gołembiowska K
Neurotox Res; 2016 Nov; 30(4):606-619. PubMed ID: 27461536
[TBL] [Abstract][Full Text] [Related]
6. Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine.
Nash JF; Yamamoto BK
Brain Res; 1992 May; 581(2):237-43. PubMed ID: 1356579
[TBL] [Abstract][Full Text] [Related]
7. Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced neurotoxicity in the rat.
Hekmatpanah CR; McKenna DJ; Peroutka SJ
Neurosci Lett; 1989 Sep; 104(1-2):178-82. PubMed ID: 2573011
[TBL] [Abstract][Full Text] [Related]
8. Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats.
Kehr J; Ichinose F; Yoshitake S; Goiny M; Sievertsson T; Nyberg F; Yoshitake T
Br J Pharmacol; 2011 Dec; 164(8):1949-58. PubMed ID: 21615721
[TBL] [Abstract][Full Text] [Related]
9. Effect of the combination of mephedrone plus ethanol on serotonin and dopamine release in the nucleus accumbens and medial prefrontal cortex of awake rats.
López-Arnau R; Buenrostro-Jáuregui M; Camarasa J; Pubill D; Escubedo E
Naunyn Schmiedebergs Arch Pharmacol; 2018 Mar; 391(3):247-254. PubMed ID: 29349706
[TBL] [Abstract][Full Text] [Related]
10. A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds.
Colado MI; Green AR
Br J Pharmacol; 1994 Jan; 111(1):131-6. PubMed ID: 7516800
[TBL] [Abstract][Full Text] [Related]
11. Locomotor stimulation produced by 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain.
Baumann MH; Clark RD; Rothman RB
Pharmacol Biochem Behav; 2008 Aug; 90(2):208-17. PubMed ID: 18403002
[TBL] [Abstract][Full Text] [Related]
12. Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMA.
Angoa-Pérez M; Kane MJ; Briggs DI; Francescutti DM; Sykes CE; Shah MM; Thomas DM; Kuhn DM
J Neurochem; 2013 Apr; 125(1):102-10. PubMed ID: 23205838
[TBL] [Abstract][Full Text] [Related]
13. The Effects of Exposure to Mephedrone During Adolescence on Brain Neurotransmission and Neurotoxicity in Adult Rats.
Kamińska K; Noworyta-Sokołowska K; Górska A; Rzemieniec J; Wnuk A; Wojtas A; Kreiner G; Kajta M; Gołembiowska K
Neurotox Res; 2018 Oct; 34(3):525-537. PubMed ID: 29713996
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of substituted amphetamines (PMA, MDMA, and METH) on monoamines in rat caudate: a microdialysis study.
Gough B; Imam SZ; Blough B; Slikker W; Ali SF
Ann N Y Acad Sci; 2002 Jun; 965():410-20. PubMed ID: 12105116
[TBL] [Abstract][Full Text] [Related]
15. Comparative actions of monomethoxyamphetamines on the release and uptake of biogenic amines in brain tissue.
Tseng LF; Menon MK; Loh HH
J Pharmacol Exp Ther; 1976 May; 197(2):263-71. PubMed ID: 1271280
[TBL] [Abstract][Full Text] [Related]
16. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
Battaglia G; Yeh SY; O'Hearn E; Molliver ME; Kuhar MJ; De Souza EB
J Pharmacol Exp Ther; 1987 Sep; 242(3):911-6. PubMed ID: 2443644
[TBL] [Abstract][Full Text] [Related]
17. Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA).
Slikker W; Ali SF; Scallet AC; Frith CH; Newport GD; Bailey JR
Toxicol Appl Pharmacol; 1988 Jul; 94(3):448-57. PubMed ID: 2456631
[TBL] [Abstract][Full Text] [Related]
18. Effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE) on central serotonergic and dopaminergic systems of the rat.
Johnson M; Hanson GR; Gibb JW
Biochem Pharmacol; 1987 Dec; 36(23):4085-93. PubMed ID: 2446629
[TBL] [Abstract][Full Text] [Related]
19. Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat.
O'Loinsigh ED; Boland G; Kelly JP; O'Boyle KM
Prog Neuropsychopharmacol Biol Psychiatry; 2001 Apr; 25(3):621-38. PubMed ID: 11371001
[TBL] [Abstract][Full Text] [Related]
20. Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue.
Schmidt CJ; Wu L; Lovenberg W
Eur J Pharmacol; 1986 May; 124(1-2):175-8. PubMed ID: 2424776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
